Sammenlign metoder

	Cost-Utility Analysis	Cost-Effectiveness Analysis for Policy
Fagfelt	Public Policy	Public Policy
Familie	Process / pipeline	Process / pipeline
Opprinnelsesår	2015	2015
Opphavsperson	Health-economics community; standardised by Drummond and colleagues	Health-economics and program-evaluation tradition (Drummond et al.; Gold et al.)
Type	Economic evaluation expressing outcomes in utility-weighted health	Economic evaluation comparing cost per unit of effect
Opprinnelig kilde	Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the Economic Evaluation of Health Care Programmes (4th ed.). Oxford: Oxford University Press. ISBN: 9780199665877	Drummond, M. F., Sculpher, M. J., Claxton, K., Stoddart, G. L., & Torrance, G. W. (2015). Methods for the Economic Evaluation of Health Care Programmes (4th ed.). Oxford: Oxford University Press. ISBN: 9780199665877
Alias	CUA, Cost per QALY Analysis, QALY-Based Economic Evaluation	Policy Cost-Effectiveness Analysis, CEA for Policy, Cost-Utility Analysis in Policy
Relaterte	3	4
Sammendrag	Cost-utility analysis (CUA) is a form of economic evaluation that compares the costs of alternative interventions with their outcomes expressed in a common, preference-based measure of health — most often the quality-adjusted life year (QALY), or in global health the disability-adjusted life year (DALY). By combining length and quality of life into a single index, CUA allows interventions with very different effects to be compared on a like-for-like basis, and it produces an incremental cost-effectiveness ratio expressed as cost per QALY gained. It is the dominant method for informing decisions about which health technologies and programs to fund.	Cost-effectiveness analysis (CEA) is an economic evaluation that compares competing policies or programs by their cost relative to a single, common measure of effect — lives saved, cases averted, years of education gained, or quality-adjusted life years (QALYs). Rather than valuing outcomes in money, CEA expresses results as an incremental cost-effectiveness ratio (ICER): the extra cost of one option per extra unit of outcome it delivers compared with the next-best alternative. Codified in standard references such as Drummond and colleagues' Methods for the Economic Evaluation of Health Care Programmes and the US Panel's Cost-Effectiveness in Health and Medicine, CEA is the dominant appraisal tool for health and increasingly for other public programs with a shared outcome metric.